Paper38680717
Lymphocyte Level at Diagnosis in Hodgkin lymphoma: Could It be an Indicator of the Stage at Initial Diagnosis?
Goze H and 3 others. Int J Hematol Oncol Stem Cell Res, 2024. Cited by 0 papers, by iCite.
Cite this record
ConductScience Library. Lymphocyte Level at Diagnosis in Hodgkin lymphoma: Could It be an Indicator of the Stage at Initial Diagnosis? Papers, record 38680717. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/38680717
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Lymphocyte Level at Diagnosis in Hodgkin lymphoma: Could It be an Indicator of the Stage at Initial Diagnosis?
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References17
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 18924115 | Prognostic impact of tumour-infiltrating Th2 and regulatory T cells in classical Hodgkin lymphoma. | Hematol Oncol | 2009 | https://conductscience.org/library/papers/18924115 | PubMed |
| 2 | 22360654 | Peripheral blood lymphocyte/monocyte ratio at diagnosis and survival in nodular lymphocyte-predominant Hodgkin lymphoma. | Br J Haematol | 2012 | https://conductscience.org/library/papers/22360654 | PubMed |
| 3 | 11255273 | Whole-body positron emission tomography using 18F-fluorodeoxyglucose compared to standard procedures for staging patients with Hodgkin's disease. | Haematologica | 2001 | https://conductscience.org/library/papers/11255273 | PubMed |
| 4 | 32384177 | Hodgkin lymphoma: A 2020 update on diagnosis, risk-stratification, and management. | Am J Hematol | 2020 | https://conductscience.org/library/papers/32384177 | PubMed |
| 5 | 24202395 | Microenvironmental regulation of tumor progression and metastasis. | Nat Med | 2013 | https://conductscience.org/library/papers/24202395 | PubMed |
| 6 | 23161719 | Prognostic significance of the ratio of absolute neutrophil count to absolute lymphocyte count in classic Hodgkin lymphoma. | Am J Clin Pathol | 2012 | https://conductscience.org/library/papers/23161719 | PubMed |
| 7 | 25113753 | Recommendations for initial evaluation, staging, and response assessment of Hodgkin and non-Hodgkin lymphoma: the Lugano classification. | J Clin Oncol | 2014 | https://conductscience.org/library/papers/25113753 | PubMed |
| 8 | 31864143 | Diffusion-weighted MRI for initial staging in Hodgkin`s lymphoma: comparison with FDG PET. | Eur J Radiol | 2020 | https://conductscience.org/library/papers/31864143 | PubMed |
| 9 | 18332908 | The relationship between absolute lymphocyte count with PFS in patients with Hodgkin's lymphoma undergoing autologous hematopoietic cell transplant. | Bone Marrow Transplant | 2008 | https://conductscience.org/library/papers/18332908 | PubMed |
| 10 | 9819449 | A prognostic score for advanced Hodgkin's disease. International Prognostic Factors Project on Advanced Hodgkin's Disease. | N Engl J Med | 1998 | https://conductscience.org/library/papers/9819449 | PubMed |
| 11 | 21993683 | Peripheral blood lymphocyte/monocyte ratio at diagnosis and survival in classical Hodgkin's lymphoma. | Haematologica | 2012 | https://conductscience.org/library/papers/21993683 | PubMed |
| 12 | 32502987 | Hodgkin Lymphoma, Version 2.2020, NCCN Clinical Practice Guidelines in Oncology. | J Natl Compr Canc Netw | 2020 | https://conductscience.org/library/papers/32502987 | PubMed |
| 13 | 20220182 | Tumor-associated macrophages and survival in classic Hodgkin's lymphoma. | N Engl J Med | 2010 | https://conductscience.org/library/papers/20220182 | PubMed |
| 14 | 27607161 | Comparison of PET/MRI With PET/CT in the Evaluation of Disease Status in Lymphoma. | Clin Nucl Med | 2017 | https://conductscience.org/library/papers/27607161 | PubMed |
| 15 | 26046410 | Absolute Monocyte Count and Lymphocyte-Monocyte Ratio Predict Outcome in Nodular Sclerosis Hodgkin Lymphoma: Evaluation Based on Data From 1450 Patients. | Mayo Clin Proc | 2015 | https://conductscience.org/library/papers/26046410 | PubMed |
| 16 | 24357794 | The derived neutrophil to lymphocyte ratio is an independent prognostic factor in patients with diffuse large B-cell lymphoma. | Br J Cancer | 2014 | https://conductscience.org/library/papers/24357794 | PubMed |
| 17 | 30739242 | Efficacy of nivolumab as checkpoint inhibitor drug on survival rate of patients with relapsed/refractory classical Hodgkin lymphoma: a meta-analysis of prospective clinical study. | Clin Transl Oncol | 2019 | https://conductscience.org/library/papers/30739242 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Cited by
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/38680717
GET https://conductscience.org/api/papers/v1/38680717/authors